
SynX Pharma Inc. — Investor Relations & Filings
SynX Pharma Inc. is a biotechnology firm specializing in the discovery, development, and commercialization of healthcare products and services, with a historical emphasis on medical diagnostics. The company's portfolio included proprietary in vitro diagnostic technology, notably an application utilizing glutamine synthetase as a marker for Alzheimer's disease. This diagnostic technology was previously licensed exclusively for human applications. SynX Pharma focuses on providing specialized diagnostic solutions within the healthcare sector.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Material change report - English.pdf | 2004-03-12 | English | |
| Material change report - English.pdf | 2003-07-14 | English | |
| Material change report - English.pdf | 2003-07-11 | English | |
| Material change report - English.pdf | 2002-10-16 | English | |
| Other material contract(s).pdf | 2001-09-06 | English | |
| Final Receipt.PDF | 2001-07-19 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2004
1 filing
| |||||
| 47832712 | Material change report - English.pdf | 2004-03-12 | English | ||
|
2003
2 filings
| |||||
| 47832714 | Material change report - English.pdf | 2003-07-14 | English | ||
| 47832782 | Material change report - English.pdf | 2003-07-11 | English | ||
|
2002
1 filing
| |||||
| 47832785 | Material change report - English.pdf | 2002-10-16 | English | ||
|
2001
6 filings
| |||||
| 47832788 | Other material contract(s).pdf | 2001-09-06 | English | ||
| 47832819 | Final Receipt.PDF | 2001-07-19 | English | ||
| 47832822 | Other material contract(s).pdf | 2001-07-19 | English | ||
| 47832830 | Preliminary Receipt.PDF | 2001-06-06 | English | ||
| 47832833 | Preliminary long form prospectus - English.pdf | 2001-06-06 | English | ||
| 47832861 | Material change report - English.pdf | 2001-05-09 | English | ||
|
2000
5 filings
| |||||
| 47832864 | Final Receipt.pdf | 2000-11-02 | English | ||
| 47832867 | Final long form prospectus - English.pdf | 2000-11-01 | English | ||
| 47832875 | Preliminary Receipt.PDF | 2000-10-04 | English | ||
| 47832921 | Preliminary long form prospectus - English.pdf | 2000-10-03 | English | ||
| 47832923 | Material change report - English.pdf | 2000-08-22 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
Develops and sells consumer healthcare and prescription dru…
|
000999 | CN | Manufacturing |
|
China Shineway Pharmaceutical Group Limited
R&D, manufacturing, and distribution of modern Chinese medi…
|
2877 | KY | Manufacturing |
|
China SXT Pharmaceuticals, Inc.
Researches, develops, manufactures, and sells traditional C…
|
SXTC | VG | Manufacturing |
|
China Traditional Chinese Medicine Holdings Co. Limited
Specializes in the full value chain of TCM, including R&D, …
|
570 | HK | Manufacturing |
|
ChoA Pharmaceutical Co., LTD.
Develops, manufactures, and sells pharmaceutical products a…
|
034940 | KR | Manufacturing |
|
Chong Kun Dang Pharmaceutical Corp.
Develops and manufactures drugs for systemic anti-infective…
|
185750 | KR | Manufacturing |
|
CHONGQING GENRIX BIOPHARMACEUTICAL CO., LTD.
Researches, develops, and manufactures monoclonal antibodie…
|
688443 | CN | Manufacturing |
|
Chongqing Lummy Pharmaceutical Co.,Ltd.
Produces anti-infective, cardiovascular, gastrointestinal, …
|
300006 | CN | Manufacturing |
|
Chongqing Pharscin Pharmaceutical Co., Ltd.
Integrated developer of chemical drugs and modern TCM for d…
|
002907 | CN | Manufacturing |
|
CHONGQING TAIJI INDUSTRY (GROUP) CO.,LTD
Manufactures and distributes traditional Chinese medicine a…
|
600129 | CN | Manufacturing |
SynX Pharma Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/44618/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=44618 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=44618 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=44618 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 44618}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for SynX Pharma Inc. (id: 44618)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.